Standard therapy for advanced recurring aggressive, haematological malignancies, such as leukaemias and lymphomas, have a…
To understand blood cancer, it is important to know it mainly affects the bone marrow,…
A survey by the charity Blood Cancer UK has found that over half of UK…
Research led by the University of Southampton, UK, has revealed a new fundamental feature of…
MUSC Hollings Cancer Center (USA) was one of 28 clinical sites around the world that…
For their own benefit and to grow beyond control, tumours manipulate cell signals to make…
A new class of drugs that inhibits a “master switch” involved in the vast majority…
DESCAR-T is the French national registry for patients treated with commercial chimeric antigen receptor (CAR)-T…
Many early-stage patients with bulky classic Hodgkin lymphoma (cHL) can avoid radiotherapy treatment and still…
Preclinical study supports clinical trial of cord blood-derived natural killer cells with Affimed’s AFM13 as…